243 related articles for article (PubMed ID: 19698076)
1. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases.
Kimura H; Miyake K; Yamauchi Y; Nishiyama K; Iwata S; Iwatsuki K; Gotoh K; Kojima S; Ito Y; Nishiyama Y
J Infect Dis; 2009 Oct; 200(7):1078-87. PubMed ID: 19698076
[TBL] [Abstract][Full Text] [Related]
2. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
5. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
[TBL] [Abstract][Full Text] [Related]
6. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
8. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
[TBL] [Abstract][Full Text] [Related]
9. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
11. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
[TBL] [Abstract][Full Text] [Related]
12. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
[TBL] [Abstract][Full Text] [Related]
13. Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation.
Torre-Cisneros J; Román J; Torres A; Herrera C; Caston JJ; Rivero A; Mingot E; Rojas R; Martín C; Martínez F; Gómez P
J Infect Dis; 2004 Nov; 190(9):1596-9. PubMed ID: 15478063
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated lymphoproliferative disorders.
Ambinder RF
Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus suspension cell assay using in situ hybridization and flow cytometry.
Crouch J; Leitenberg D; Smith BR; Howe JG
Cytometry; 1997 Sep; 29(1):50-7. PubMed ID: 9298811
[TBL] [Abstract][Full Text] [Related]
18. [Epstein-Barr virus and post-transplantation lymphoproliferations].
Leblond V
Ann Med Interne (Paris); 1997; 148(5):376-8. PubMed ID: 9538412
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Epstein-Barr virus in lymphoproliferative diseases of the lung.
Shimakage M; Sakamoto H; Harada S; Sasagawa T; Kodama K
Oncol Rep; 2007 Jun; 17(6):1347-52. PubMed ID: 17487389
[TBL] [Abstract][Full Text] [Related]
20. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
Yajima M; Kanda T; Takada K
J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]